Clinical research agreements: December updates

Published December 20, 2023

Print

The University at Buffalo Clinical Research Office is sharing updates on industry-sponsored clinical research agreements.

Oversight and transition:

  • Conor Flynn, Director of Research Administration for the Jacobs School Office of Research, is now overseeing industry-sponsored clinical research agreements.
  • A transition from Technology Transfer and an unfilled position caused a temporary delay in contracts processing from June to late October.

Full staffing and introduction of the contracts team:

  • The contracts team is now fully staffed to efficiently manage industry-sponsored clinical research agreements. The team consists of:
    • Conor Flynn, Director of Research Administration
    • Ryan McAnany, Contracts Manager (formerly with Technology Transfer)
    • Lucia O'Quinn, Contracts Manager (recent UB law graduate, joined in October)
    • The WIRB-Copernicus Group (WCG), a leading provider of regulatory and ethical review services for clinical research, is also assisting where necessary.

Exciting milestone: SUNY-wide Master Clinical Trial Agreements:

  • After four years of negotiations, UB has successfully led the completion of the SUNY-wide Master Clinical Trial Agreement (MCTA) with Abbvie.
  • This master agreement applies to all SUNY campuses conducting clinical research.

Key highlights of MCTAs:

  • Pre-negotiated terms with industry sponsors, like Abbvie, significantly reduce contract cycle time, from 3-4 months to just a couple of days.
  • UB's growing list of SUNY-wide MCTAs includes agreements with industry leaders, fostering growth in our clinical research operation.

List of SUNY-wide MCTAs and Master NDAs:

MCTAs:

  • Abbvie
  • Intercept Pharmaceuticals
  • Pharmaceutical Research Associates International (CRO)
  • Bayer
  • Novo Nordisk
  • Novartis
  • Penumbra
  • Beckman Coulter
  • Astellas
  • Medtronic
  • Biogen
  • Amgen
  • Edwards Lifesciences
  • Genentech
  • Boston Scientific
  • Celgene
  • Vertex
  • Boehringer Ingelheim
  • Gilead
  • Eli Lilly
  • Sanofi-Aventis
  • Abiomed

Master NDAs:

  • PPD Investigator Services (CRO)
  • AstraZeneca
  • Eli Lilly

New master premises agreement with Erie County Medical Center:

  • The new agreement permits UB investigators to conduct clinical research more easily in ECMC-owned space.

For questions or additional information, contact the Office of Research at medicine@research.buffalo.edu.